Kristine M. Ball Joins Relypsa, Inc. as Senior Vice President, Chief Financial Officer

SANTA CLARA, Calif.--(BUSINESS WIRE)--Relypsa, Inc., a clinical-stage biopharmaceutical company, announced today the appointment of Kristine M. Ball to the position of Senior Vice President and Chief Financial Officer. She will be responsible for overseeing Relypsa’s finance, accounting and investor relations functions. “It is with great pleasure that we welcome Kristine to Relypsa during this important time in the company’s evolution,” stated Gerrit Klaerner, Ph.D., President of Relypsa. "The next 18 months will be an exciting time for Relypsa filled with many key value driving milestones, including completion of our phase 3 clinical program for patiromer and filing a New Drug Application with the FDA shortly thereafter. With Kristine’s extensive strategic and financial experience, she will bring additional strength and leadership to our management team as we drive towards these milestones and progress toward becoming a commercial company.”

Back to news